Perrigo Co. Plc Hits New 52-Week Low at USD 20.52

Perrigo Co. Plc, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 20.52 as of September 22, 2025. This marks a significant decline for the company, which has seen its stock price drop by 23.66% over the past year, contrasting sharply with the S&P 500's performance of 16.64% during the same period.
The company's financial metrics reveal a challenging landscape. Perrigo's market capitalization stands at USD 3,072 million, and it currently operates at a loss, reflected in its negative price-to-earnings ratio. The firm has a debt-to-equity ratio of 0.72 and a return on equity of 0.37%, indicating a cautious financial position. Additionally, the stock's price-to-book ratio is 0.69, suggesting it may be undervalued relative to its assets.

Recent financial results have shown a net profit loss of USD 67.46 million over the past nine months, with a staggering decline in pre-tax profit of 90.52% in the latest quarter. The rise in raw material costs by 7.52% year-over-year further complicates the company's operational outlook. Overall, Perrigo's consistent underperformance against market benchmarks highlights the challenges it faces in the current economic environment.